Mounjaro side effects in PCOS: what the evidence says and who to talk to

Step 1: understand which side effects you're actually likely to notice

The gastrointestinal effects are the most common experience in the first few weeks. Nausea tends to peak after a new dose is introduced and settles for most people within a fortnight. Constipation, loose stools, bloating and reflux show up too, usually mild and transient. Fatigue, headache and dizziness appear less often. You can read a full breakdown of the tirzepatide side-effect list on the Mounjaro side effects overview that our clinical team maintains.

For women with PCOS specifically, one practical habit is worth building into your first few weeks: before each dose day, take two minutes to note how your digestion, energy and cycle feel. It sounds simple, but having a rough record makes it far easier to tell your prescriber whether a symptom started with treatment or was already there. PCOS already brings cycle irregularity and fatigue; separating the two matters.

The NHS medicines page for tirzepatide lists every reported side effect with frequency data, and it is worth a read before you start. Injection-site redness or firmness is common and usually resolves; rotate between your abdomen, thigh and upper arm to minimise it.

Step 2: know which PCOS-specific interactions need your prescriber's attention

PCOS is driven partly by insulin resistance, and tirzepatide acts on two gut-hormone pathways (GIP and GLP-1) that are deeply involved in insulin and appetite signalling. As insulin sensitivity improves and weight falls, some women with PCOS notice their periods becoming more regular. That sounds positive, and often is, but it also means fertility may return or increase. If pregnancy is not your intention right now, contraception planning is not optional.

The NHS England guidance on weight-management injections is explicit: women taking oral contraceptives should use an additional non-oral method during the first four weeks of Mounjaro and for four weeks after each dose increase. Tirzepatide slows gastric emptying, which can reduce how well an oral pill is absorbed. This is not a theoretical risk, it is a practical one the MHRA and NHS both flag. Condoms or a barrier method alongside your pill covers it.

There is a fuller discussion of what happens at the 5mg dose step, where GI effects sometimes intensify, on the 5mg Mounjaro side effects page. If you are on oral contraceptives and moving up a dose, the four-week non-oral cover restarts.

HRT is another consideration for some women with PCOS. NHS England advises considering transdermal formats (patches or gels) rather than oral HRT while on tirzepatide, for the same absorption reason. Raise this with your GP or prescriber before your first pen arrives.

Step 3: recognise the symptoms that need same-day medical attention

Most side effects are manageable and self-limiting. A few are not. The MHRA's Drug Safety Update published in January 2026 specifically highlighted acute pancreatitis as a known, infrequent but potentially serious risk with GLP-1 receptor agonist medicines, and tirzepatide sits in that class. The warning sign is severe, persistent abdominal pain that may reach through to the back, with or without vomiting. Stop treatment and seek urgent medical help if this happens. Do not wait to see whether it settles.

Gallbladder problems (pain in the upper right abdomen, especially after eating) are also worth reporting promptly. Significant weight loss of any cause can increase gallstone risk, and PCOS is itself associated with a somewhat higher baseline rate of gallbladder issues. If you are wondering whether a particular symptom is linked to treatment, our guide to identifying each side effect of Mounjaro walks through the most commonly reported ones and what they typically feel like. Dehydration from persistent vomiting or diarrhoea can strain the kidneys; staying hydrated matters particularly in those early titration weeks.

You can report any suspected side effect directly to the MHRA through the Yellow Card scheme, that feedback shapes future safety guidance. And if you have questions between doses, the contact page reaches our aftercare team seven days a week.

Step 4: pregnancy, trying to conceive, and what 'not recommended' actually means

Tirzepatide is not licensed for use in pregnancy, during breastfeeding, or if you are trying to conceive. That guidance applies to everyone, but it carries particular weight for women with PCOS. Improved insulin sensitivity during treatment can restore ovulation even in women who had not been ovulating regularly for years. Clinically that is meaningful, but it means contraception conversations cannot be an afterthought.

If your plans change and you want to try for a pregnancy, speak to your prescriber well in advance. A wash-out period before conception is advised, and your prescriber will guide you on timing. Some people also ask at this stage what to expect if side effects from Mounjaro persist after stopping, and our clinical guidance covers that too. This is one of those conversations our team at our clinical team has regularly, and it is much easier to plan before stopping treatment than after.

Mounjaro is also not licensed for anyone under 18. If you have a teenage daughter with PCOS asking about this treatment, the short answer is that it is not appropriate, and a paediatric endocrinologist is the right route. Our FAQs cover eligibility questions in more detail for adults considering private treatment, and if you are still weighing up whether this medicine is right for you, our Mounjaro information page sets out how it works, who it suits, and what the treatment journey typically involves. If you are among those who find they experience no side effects on Mounjaro, that is entirely possible and nothing to be concerned about.